Riskpilot← Back to searchSign inGet full accessHELION BIOTECH ApS
APSActiveCVR 31758106Drosselvej 53HResearch and experimental development on natural sciences and engineering · NACE 7210Est. 2008— employees
Revenue 2024
DKK -45K
-275% vs 2023
EBITDA margin
100.0%
+31% vs 2023
Equity ratio
74.1%
Financial strength
Net profit 2024
DKK -44K
+9% vs 2023
| Revenue | DKK -45K | -275% |
| EBITDA | DKK -45K | +31% |
| Net profit | DKK -44K | +9% |
| Total assets | DKK 202K | -20% |
| Equity | DKK 150K | -23% |
| Employees | — | — |
Legal name
HELION BIOTECH ApS
CVR number
31758106
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2. september 2008
Share capital
DKK 166.647
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af enten 3 bestyrelsesmedlemmer i forening eller selskabets administrerende direktør alene.
Company purpose
Selskabets formål er at udvikle farmaceutiske lægemidler og dermed beslægtet virksomhed.
Address
Drosselvej 53H
Phone
+4520252038
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 524 | 2.924 | -105 | -82 | -12 | 5.004 | -18 | 34 | 55 | 33 | 26 | -45 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 34 | 524 | 2.924 | -105 | -82 | -12 | 5.004 | -18 | 34 | 17 | 33 | -65 | -45 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 34 | 524 | 2.924 | -105 | -82 | -12 | 5.004 | -18 | 34 | 17 | 33 | -65 | -45 |
| Net financials | 0 | -2 | -5 | 0 | -2 | -1 | -1 | -5 | -3 | -3 | -2 | 1 | 1 |
| Profit before tax | 34 | 522 | 2.919 | -105 | -84 | -14 | 5.003 | -23 | 31 | 15 | 31 | -64 | -44 |
| Tax | 10 | 133 | 720 | -0 | -0 | -0 | 1.058 | -0 | 3 | 3 | 10 | -16 | -0 |
| Net profit | 24 | 389 | 2.199 | -105 | -84 | -14 | 3.945 | -23 | 28 | 11 | 22 | -48 | -44 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 219 | 762 | 3.303 | 2.116 | 963 | 287 | 1.110 | 576 | 535 | 456 | 415 | 251 | 202 |
| Equity | 192 | 582 | 2.535 | 2.095 | 932 | 218 | 563 | 181 | 209 | 220 | 242 | 193 | 150 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 26 | 181 | 768 | 20 | 31 | 69 | 547 | 395 | 323 | 229 | 158 | 58 | 52 |
| Total debt | 26 | 181 | 768 | 20 | 31 | 69 | 547 | 395 | 323 | 229 | 158 | 58 | 52 |
EBITDA margin
-4504500.0%
This company
15.8%
Market median
-28509594% vs market
20122024
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
20122024
Return on equity
-29.4%
This company
18.4%
Market median
-260% vs market
20122024
Net profit margin
-4389500.0%
This company
8.1%
Market median
-54191458% vs market
20122024
Asset turnover
-0.22×
This company
1.12×
Market median
-120% vs market
20122024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JV Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
PB Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — | |
| Chairman | 2008 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HELION HOLDING ApS | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HELION HOLDING ApS
HELION BIOTECH ApS Board members of HELION BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeppe Vesti Christensen | Chief Executive Officer | 0 companies |
| Per Bo Pedersen Fischer | Chief Executive Officer | 0 companies |
| Steffen Thiel | Chairman | 0 companies |
| Ole Bitsch-Jensen | Chairman | 0 companies |
| Jens Christian Jensenius | Board of Directors | 0 companies |